TransThera Biosciences is a startup biotech focused on discovering and developing novel NCE drugs. Its pipeline covers disease areas including oncology and cardiovascular diseases. The company says it will adopt a novel business model embracing open innovation and aims to become an innovation platform company. TransThera is led by founder and CEO Dr. Frank Wu, a veteran in NCE discovery and development. Financially, the company closed a Series A financing close to US$10M to support its drug-development efforts. The company is located in the Pharma Valley of Nanjing’s High‑Tech Zone, within about one hour from Shanghai by high‑speed train.

Total raised

$10M

Funding rounds

1

Latest round

Series A

Latest activity

Oct 2016